HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Branko Cuglievan Selected Research

Mitogen-Activated Protein Kinases

1/2022Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase/extracellular signal-regulated kinase pathway activation.
1/2021Coincidental Expression of Classic Hodgkin Lymphoma and Neurofibromatosis Type I and Literature Review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Branko Cuglievan Research Topics

Disease

17Neoplasms (Cancer)
04/2024 - 01/2018
12Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2024 - 09/2021
11Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 01/2021
5Sarcoma (Soft Tissue Sarcoma)
01/2022 - 01/2018
4Leukemia
02/2024 - 01/2022
4Ewing Sarcoma (Sarcoma, Ewing)
07/2020 - 10/2018
3Philadelphia Chromosome
02/2024 - 01/2023
3Hodgkin Disease (Hodgkin's Disease)
11/2023 - 01/2022
2Down Syndrome (Down's Syndrome)
03/2024 - 01/2023
2Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2023 - 02/2023
2Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 01/2021
2Desmoplastic Small Round Cell Tumor
10/2018 - 01/2018
1Lymphoma (Lymphomas)
03/2024
1Hyperplasia
03/2024
1Inflammation (Inflammations)
02/2024
1Systemic Mastocytosis
01/2024
1Monosomy
03/2023
1monosomy Chromosome 7
03/2023
1Residual Neoplasm
01/2023
1Hematologic Diseases (Blood Diseases)
12/2022
1Multiple Myeloma
11/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Sinus Histiocytosis (Rosai-Dorfman Disease)
01/2022
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2021
1Carcinoma (Carcinomatosis)
12/2021
1Circulating Neoplastic Cells
12/2021
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
11/2021
1Pancreatitis
09/2021
1Sepsis (Septicemia)
01/2021
1Acute Lung Injury
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2020

Drug/Important Bio-Agent (IBA)

4blinatumomabIBA
03/2024 - 01/2023
4venetoclaxIBA
11/2023 - 10/2021
3Biomarkers (Surrogate Marker)IBA
02/2024 - 07/2020
2Transcription Factors (Transcription Factor)IBA
05/2024 - 12/2021
2DecitabineFDA Link
01/2024 - 10/2021
2Inotuzumab OzogamicinIBA
12/2023 - 01/2023
2Lysine (L-Lysine)FDA Link
01/2023 - 01/2021
2MethyltransferasesIBA
01/2023 - 01/2021
2Mitogen-Activated Protein KinasesIBA
01/2022 - 01/2021
1Cytarabine (Cytosar-U)FDA LinkGeneric
03/2024
1palbociclibIBA
03/2024
1ChromatinIBA
03/2024
1HomoharringtonineIBA
02/2024
1Interferon-gamma (Interferon, gamma)IBA
02/2024
1CytokinesIBA
02/2024
1Tyrosine Kinase InhibitorsIBA
02/2024
1tagraxofuspIBA
02/2024
1avapritinibIBA
01/2024
1Core Binding Factors (Core-Binding Factor)IBA
01/2024
1Brentuximab VedotinIBA
11/2023
1nuclear pore complex protein 98IBA
03/2023
1Vincristine (Oncovin)FDA LinkGeneric
01/2023
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2023
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2023
1Chimeric Antigen ReceptorsIBA
01/2023
1Bispecific AntibodiesIBA
01/2023
1Rituximab (Mabthera)FDA Link
01/2023
1Interferon Regulatory FactorsIBA
11/2022
1pembrolizumabIBA
01/2022
1tisagenlecleucelIBA
01/2022
1enzalutamideIBA
01/2022
1AndrogensIBA
01/2022
1EnzymesIBA
01/2022
1Niacinamide (Nicotinamide)FDA LinkGeneric
01/2022
1Androgen Receptors (Androgen Receptor)IBA
01/2022
1TransferasesIBA
01/2022
1Antisense OligonucleotidesIBA
01/2022
1Cyclin D1IBA
01/2022
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2022
1Apoptosis Regulatory ProteinsIBA
01/2022
1gilteritinibIBA
12/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2021
1antiarrhythmic peptide (AAP)IBA
09/2021
1Asparaginase (Elspar)FDA Link
09/2021
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
07/2020
1AntibodiesIBA
07/2020
1caprolactoneIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
12/2019
1PlasticsIBA
12/2019
1Immunoconjugates (Immunoconjugate)IBA
01/2019
1PerforinIBA
01/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1Monoclonal AntibodiesIBA
01/2019
1EndoglinIBA
01/2019
1Streptonigrin (Nigrin)IBA
01/2019
1Cisplatin (Platino)FDA LinkGeneric
10/2018

Therapy/Procedure

17Therapeutics
04/2024 - 01/2018
9Drug Therapy (Chemotherapy)
03/2024 - 01/2018
4Immunotherapy
03/2023 - 01/2021
2Stem Cell Transplantation
12/2023 - 01/2022
2Hematopoietic Stem Cell Transplantation
02/2023 - 01/2023
2Critical Care (Surgical Intensive Care)
01/2022 - 01/2021
1Autologous Transplantation
11/2023
1Infant Equipment (Crib)
01/2023
1Bioreactors (Bioreactor)
12/2021
1Salvage Therapy
10/2021
1Cell Transplantation
01/2021
1Transplantation
01/2021
1Combination Drug Therapy (Combination Chemotherapy)
12/2019